ArticleJournal of Cancer2019

Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma

Ayse Hande Nayman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.